A new study suggests that certain signals in the blood, known as inflammation markers, may be linked to depression in women with type 2 diabetes. However, the relationship is not simple.
The findings show that these markers can change depending on how depression is measured and what symptoms a person has. This research was led by scientists at NYU Rory Meyers College of Nursing and published in the journal Frontiers in Psychiatry.
Depression and type 2 diabetes often occur together. Women with type 2 diabetes are more likely to experience depression compared to the general population. This combination can make health outcomes worse.
Depression can reduce a person’s ability to manage their diabetes, leading to higher blood sugar levels and more complications over time. It can also increase the risk of serious health problems and even early death.
Scientists believe that inflammation may be one of the key links between these two conditions. Inflammation is the body’s natural response to injury or illness, but when it becomes long-lasting, it can harm the body.
Certain inflammatory markers, which can be measured in the blood, are often found at higher levels in both people with diabetes and those with depression.
Despite this connection, doctors still do not have a clear biological test to diagnose depression. Instead, mental health professionals usually rely on questionnaires. Some of these tools count the number of symptoms, while others measure how severe the symptoms are.
However, depression is not the same for everyone. Some people experience mainly emotional symptoms, such as sadness, while others may have physical symptoms like poor sleep or fatigue, or cognitive problems such as difficulty concentrating.
Because of this variety, it can be difficult to study depression using a single approach. In this study, researchers wanted to better understand how inflammation is linked to different types of depression symptoms.
The research team studied 38 women with type 2 diabetes. Many of the participants were also living with HIV, which can also affect inflammation levels. The scientists collected blood samples and tested for 10 different inflammatory markers, including CRP, IL-6, IL-4, and IL-8.
To measure depression, they used two different tools. One was PROMIS, a modern system developed by the National Institutes of Health that measures different aspects of mental health, such as depression, anxiety, sleep, and fatigue. The other was CES-D, an older scale that combines multiple depression symptoms into a single score.
The results were complex. Some inflammatory markers were linked to depression, but the direction of the relationship changed depending on how depression was measured. For example, higher levels of depression and anxiety measured with PROMIS were linked to lower levels of IL-4.
At the same time, markers like CRP and IL-6 showed opposite patterns depending on the measurement tool. They were linked to higher depression scores using CES-D but lower scores using PROMIS.
The study also found that sleep problems were linked to another marker, IL-8. This shows that different symptoms of depression may be connected to different biological processes in the body.
These findings suggest that depression may not be a single condition, but rather a group of related conditions with different causes. This could explain why it has been so difficult to find a single biomarker for depression.
Although the study was small and more research is needed, it highlights an important idea. Looking at both symptoms and biological markers together may help doctors better understand and treat depression in the future.
The researchers believe this approach could lead to what is known as precision mental health. Instead of using the same treatment for everyone, doctors could tailor treatments based on a person’s specific symptoms and biology. For example, if a certain type of depression is linked to inflammation, treatments that target inflammation might be more effective.
In addition, having a biological test for depression could help reduce stigma. If depression can be shown through blood tests, it may help people see it as a medical condition, similar to other diseases.
In the future, combining blood tests with mental health assessments may help doctors diagnose depression earlier and choose treatments more effectively. This could reduce the trial-and-error process that many patients experience when trying different medications.
Overall, this study shows that while inflammation may play a role in depression, the relationship is complex. Understanding these details could be the key to better, more personalized care for people living with both mental and physical health conditions.
If you care about health, please read studies that scientists find a core feature of depression and this metal in the brain strongly linked to depression.
For more health information, please see recent studies about drug for mental health that may harm the brain, and results showing this therapy more effective than ketamine in treating severe depression.
Copyright © 2026 Knowridge Science Report. All rights reserved.
